Spectropharma Is A Saudi Pharmaceutical Company Founded In 2019 And Based In Riyadhit Operates A Large Manufacturing Facility In Sudair Industrial Citycovering 54 000 Square Meters And Built To High Quality Standardsthe Company Focuses On Developingmanufacturingand Commercializing Pharmaceutical Products For Both Domestic And International Markets Under The Leadership Of Co Founder And Managing Director Abdulaziz Aalsheikhspectropharma Emphasizes Transformational Strategies And A High Performance Organizational Culturethe Company Offers A Range Of Branded Pharmaceuticalsincluding Treatments For Adhdepilepsyand Various Oncology Medicationsadditionallyit Supplies 14 Active Pharmaceutical Ingredientsapisand Excipientscatering To The Needs Of Generic Drug Manufacturers And Pharmaceutical Formulators Spectropharma Targets Both The Saudi Arabian Market And Export Opportunitieswith An Estimated Revenue Between $501 Million And $1 Billionthe Company Is Positioning Itself As A Key Player In Biosimilars And Specialized Therapeuticsaiming To Expand Its Reach In Regional And Global Markets
